Juber Patel
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Cancer Genomics and Diagnostics 6
-
- Ocular Oncology and Treatments 2
- Co-authors
- Tracie A. Seimon (1 shared paper)Kerry Jo Lee (1 shared paper)Rohini Sinha (1 shared paper)William B. Karesh (1 shared paper)Sarah H. Olson (1 shared paper)Walter Ian Lipkin (1 shared paper)Anton Seimon (1 shared paper)Mara Couto-Rodriguez (1 shared paper)
- Journals
- Nature Communications (3 papers)JCO Precision Oncology (3 papers)The Lancet (1 paper)Nature Genetics (1 paper)Nature Medicine (1 paper)
- Partner nations
- United StatesSwitzerlandIreland
In The Last Decade
Juber Patel
16 papers receiving 1.6k citations
Juber Patel's Hit Papers
Peers
Comparison fields: 5 of 101
- Cancer Research 413
- Oncology 586
- Pulmonary and Respiratory Medicine 480
- Genetics 74
- Pathology and Forensic Medicine 113
Countries citing papers authored by Juber Patel
This map shows the geographic impact of Juber Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juber Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juber Patel more than expected).
Fields of papers citing papers by Juber Patel
This network shows the impact of papers produced by Juber Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juber Patel. The network helps show where Juber Patel may publish in the future.
Co-authors
The 25 scholars most cited alongside Juber Patel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | HER kinase inhibition in patients with HER2- and HER3-mutant cancers Hit paper breakdown → | 2018 | 620 |
| 2 | 2018 | 199 | |
| 3 | 2019 | 172 | |
| 4 | Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study Hit paper breakdown → | 2023 | 164 |
| 5 | 2021 | 122 | |
| 6 | 2021 | 52 | |
| 7 | 2021 | 45 | |
| 8 | 2017 | 43 | |
| 9 | 2020 | 43 | |
| 10 | 2022 | 41 | |
| 11 | 2022 | 40 | |
| 12 | 2025 | 13 | |
| 13 | 2025 | 5 | |
| 14 | 2021 | 5 | |
| 15 | 2024 | 4 | |
| 16 | 2025 | 2 |
About Juber Patel
Juber Patel is a scholar working on Cancer Research, Ophthalmology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Molecular Biology, having authored 16 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (6 papers), DNA Repair Mechanisms (2 papers), Ocular Oncology and Treatments (2 papers), Lung Cancer Treatments and Mutations (2 papers), Cancer Mechanisms and Therapy (1 paper), Sarcoma Diagnosis and Treatment (1 paper), HER2/EGFR in Cancer Research (1 paper) and Salivary Gland Tumors Diagnosis and Treatment (1 paper). The work is most often cited by research in Cancer Research (413 citations), Oncology (586 citations), Pulmonary and Respiratory Medicine (480 citations), Genetics (74 citations) and Pathology and Forensic Medicine (113 citations). Juber Patel has collaborated with scholars based in United States, Switzerland and Ireland. Frequent co-authors include Tracie A. Seimon, Kerry Jo Lee, Rohini Sinha, William B. Karesh, Sarah H. Olson, Walter Ian Lipkin, Anton Seimon, Mara Couto-Rodriguez, Patricia E. Reed and Kenneth Neill Cameron. Their work appears in journals such as Nature Communications, JCO Precision Oncology, The Lancet, Nature Genetics and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.